Everything from a live-action Disney remake to the newest Mission Impossible movie will be hitting screens this summer.

Eli Lilly has agreed a deal to acquire French antibody-drug conjugate (ADC) specialist Mablink, continuing a series of transactions that build its position in what has become one of the fastest ...